Status:
COMPLETED
ARemind: A Personalized System to Remind for Adherence
Lead Sponsor:
Dimagi Inc.
Collaborating Sponsors:
Boston University
Boston Medical Center
Conditions:
Medication Adherence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main aim of this phase II proposal is to continue and complete development of a cellular phone-based system that assists patients with their medication adherence. Adherence reports will be develop...
Detailed Description
The specific study aims are described below: 1. Organize the Design, Evaluation, and Implementation Teams: The development of ARemind will be guided by design, evaluation and implementation teams. Th...
Eligibility Criteria
Inclusion
- Stable ART (no change of ART for 3 months)
- Greater than 18 years of age
- Self-report adherence \< 85%
Exclusion
- HIV-infected patients not on ART
- Non-English speaking
- Dementia (via mini mental status exam)
- Incarceration
- Legally blind and./or deaf
- User of pillboxes
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT01229722
Start Date
October 1 2011
End Date
January 1 2013
Last Update
March 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for HIV/AIDS Care and Research, Boston Medical Center
Boston, Massachusetts, United States, 02118